These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7639854)

  • 21. [The tumor suppressor p53: "guardian of our genomes"].
    Deppert W
    Med Monatsschr Pharm; 1999 Jun; 22(6):166-73. PubMed ID: 10394793
    [No Abstract]   [Full Text] [Related]  

  • 22. [P53 antibodies: a new method for the analysis of alterations of the p53 gene: application to breast cancer].
    Soussi T; Peyrat JP; Lubin R; Bonneterre J
    Pathol Biol (Paris); 1996 Apr; 44(4):232-4. PubMed ID: 8763583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site.
    Azuma K; Shichijo S; Maeda Y; Nakatsura T; Nonaka Y; Fujii T; Koike K; Itoh K
    Cancer Res; 2003 Feb; 63(4):854-8. PubMed ID: 12591737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
    Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [p53 mutation does not determine prognosis in non-Hodgkin's lymphoma].
    Osada M; Ishioka C; Murakawa Y; Ichinohasama R; Kanamaru R; Ikawa S
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):471-5. PubMed ID: 9063486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant p53: from guardian to fallen angel?
    Deppert W
    Oncogene; 2007 Apr; 26(15):2142-4. PubMed ID: 17401422
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNAs found cavorting with p53.
    Beckman M
    J Natl Cancer Inst; 2007 Nov; 99(22):1664-5. PubMed ID: 18000210
    [No Abstract]   [Full Text] [Related]  

  • 30. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inmunohistochimic expresion of p53 protein and TTS prognostic value in the larynx cancer].
    García Lozano MC; Orradre Romero JL; Caro García M; Sáez del Castillo AI; Piris Pinilla MA
    An Otorrinolaringol Ibero Am; 2004; 31(6):515-29. PubMed ID: 15663083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of phosphoprotein P53 in pathology].
    Casazza S
    Pathologica; 1993; 85(1097):321-34. PubMed ID: 8233649
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.
    Falette N; Paperin MP; Treilleux I; Gratadour AC; Peloux N; Mignotte H; Tooke N; Löfman E; Inganäs M; Bremond A; Ozturk M; Puisieux A
    Cancer Res; 1998 Apr; 58(7):1451-5. PubMed ID: 9537247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the p53 pathway.
    Pietsch EC; Humbey O; Murphy ME
    Oncogene; 2006 Mar; 25(11):1602-11. PubMed ID: 16550160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
    Lane DP
    Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study on expression of tumor suppressor gene p53 in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):647-50. PubMed ID: 8745486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 antibodies in patients with various types of cancer: assay, identification, and characterization.
    Lubin R; Schlichtholz B; Teillaud JL; Garay E; Bussel A; Wild CP
    Clin Cancer Res; 1995 Dec; 1(12):1463-9. PubMed ID: 9815945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response.
    Peller S
    Semin Cancer Biol; 1998; 8(5):379-87. PubMed ID: 10101803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer genes. Telling changes of base.
    Harris AL
    Nature; 1991 Apr; 350(6317):377-8. PubMed ID: 2011186
    [No Abstract]   [Full Text] [Related]  

  • 40. p53 in the diagnosis of human neoplasia.
    Cossman J; Schlegel R
    J Natl Cancer Inst; 1991 Jul; 83(14):980-1. PubMed ID: 2072413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.